Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive
Condition: Type 2 Diabetes Mellitus Interventions: Drug: Alogliptin; Drug: Acarbose; Drug: Metformin; Drug: Aspirin Sponsor: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 7, 2019 Category: Research Source Type: clinical trials
